Neil Kumar

Overview

Neil Kumar received an average of $267K in total compensation, including $228K in salary, at Eidos Therapeutics from 2017 to 2019. Neil Kumar also received an average of $13M at BridgeBio Pharma between 2018 and 2019.

Source: SEC filings on April 22, 2020, April 24, 2020, and April 29, 2019.

Related executives

We found four more executives who work or worked at Eidos Therapeutics and BridgeBio Pharma.

Brian Stolz

BridgeBio Pharma

Chief Operating Officer

Charles Homcy

BridgeBio Pharma

Chairman

Cameron Turtle

Eidos Therapeutics

Chief Business Officer

Uma Sinha

Eidos Therapeutics

Chief Scientific Officer

News

You may also like